Efficacy and Mechanism of Augmentation of Cognitive Behavioral Therapy With Transcranial Alternating Current Stimulation(tACS) for Obsessive-Compulsive Disorder (OCD)

The investigators recruited outpatient adults with OCD confirmed by the Mini-International Neuropsychiatric Interview (MINI). The following inclusion and exclusion criteria were also applied: Who May Qualify: - 18-60 years old - With at least 9 years of education - Y-BOCS score ≥16 - No history of serious medical, neurological illness or other psychotic disorders other than OCD (anxiety or mild to moderate depression secondary to OCD was not exclusionary) - Medication-free or had received stable medication for at least 8 weeks before entering the study and continued the same medication throughout the study Who Should NOT Join This Trial: - History of serious medical, neurological illness or other psychotic disorders other than OCD - OCD symptoms are severe, preventing the patient from completing the required assessment and examination - Serious suicide risk - Women who are pregnant or planning to become pregnant - Currently taking antiepileptic medication - Clinically significant physical illnesses or laboratory test abnormalities that have clinical significance - Previous completion of a full course of CBT/ERP treatment Always talk to your doctor about whether this trial is right for you.